Literature DB >> 8824249

Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region.

F Maurer1, R L Medcalf.   

Abstract

Plasminogen activator inhibitor type 2 (PAI-2) mRNA and antigen levels are synergistically induced in HT-1080 fibrosarcoma cells when treated with a combination of tumor necrosis factor (TNF) and phorbol 12-myristate 13-acetate (PMA). Here we demonstrate that this effect is not fully reflected at the level of gene transcription, suggesting a contribution of post-transcriptional events in this induction. Insertion of the 3'-untranslated region (3'-UTR) of PAI-2 mRNA into the 3'-UTR of a rabbit beta-globin reporter gene reduces beta-globin-PAI-2 chimeric mRNA expression in stably transfected cells. The region within the PAI-2 3'-UTR responsible for this effect is located within the 368-nucleotide sequence preceding the poly(A) tail, a segment that includes a nonameric UUAUUUAUU motif. Mutagenesis of this element abolishes the PAI-2 3'-UTR destabilizing effect, revealing a functional role for this motif. TNF and PMA co-treatment of transfected cells increases beta-globin-PAI-2 chimeric mRNA expression 3-4-fold, indicating that the inherently unstable 3'-UTR of PAI-2 mRNA can become stabilized in response to TNF and PMA. Our results indicate that induction of PAI-2 gene expression by TNF and PMA involves both direct transcription as well as mRNA stabilization, the latter involving an AU-rich nonameric motif in the 3'-UTR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824249     DOI: 10.1074/jbc.271.42.26074

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.

Authors:  Chitta S Kasyapa; Padmaja Kunapuli; Lesleyann Hawthorn; John K Cowell
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

2.  The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

Authors:  K M Dougherty; J M Pearson; A Y Yang; R J Westrick; M S Baker; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 3.  SERPINB2-its regulation and interplay with aryl hydrocarbon receptor.

Authors:  Damian Brauze
Journal:  J Appl Genet       Date:  2021-01-02       Impact factor: 3.240

4.  Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway.

Authors:  Alessia Pascale; Marialaura Amadio; Giovanni Scapagnini; Cristina Lanni; Marco Racchi; Alessandro Provenzani; Stefano Govoni; Daniel L Alkon; Alessandro Quattrone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-11       Impact factor: 11.205

5.  HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein.

Authors:  Ana Cuadrado; Cristina Navarro-Yubero; Henry Furneaux; Jochen Kinter; Peter Sonderegger; Alberto Muñoz
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

6.  Differential regulation of gene expression by protein kinase C isozymes as determined by genome-wide expression analysis.

Authors:  M Cecilia Caino; Vivian A von Burstin; Cynthia Lopez-Haber; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2011-01-20       Impact factor: 5.157

7.  SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages.

Authors:  Wayne A Schroder; Thiago D Hirata; Thuy T Le; Joy Gardner; Glen M Boyle; Jonathan Ellis; Eri Nakayama; Dilan Pathirana; Helder I Nakaya; Andreas Suhrbier
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

8.  The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

Authors:  Ekemini A Udofa; Brett W Stringer; Padmaja Gade; Donna Mahony; Marguerite S Buzza; Dhananjaya V Kalvakolanu; Toni M Antalis
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.

Authors:  H Yoshino; Y Endo; Y Watanabe; T Sasaki
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.